<li>benazepril<p>benazepril and potassium phosphates, iv both increase  serum potassium. Use Caution/Monitor. Increased risk of hyperkalemia.</p></li><li>calcium carbonate<p>calcium carbonate decreases effects of potassium phosphates, iv by cation binding in GI tract. Modify Therapy/Monitor Closely. Calcium decreases serum phosphate concentration by binding dietary phosphate. Use alternatives if available.</p></li><li>calcium citrate<p>calcium citrate decreases effects of potassium phosphates, iv by cation binding in GI tract. Modify Therapy/Monitor Closely. Calcium decreases serum phosphate concentration by binding dietary phosphate. Use alternatives if available.</p></li><li>calcium gluconate<p>calcium gluconate decreases effects of potassium phosphates, iv by cation binding in GI tract. Modify Therapy/Monitor Closely. Calcium decreases serum phosphate concentration by binding dietary phosphate. Use alternatives if available.</p></li><li>canagliflozin<p>potassium phosphates, iv and canagliflozin both increase  serum potassium. Use Caution/Monitor.</p></li><li>captopril<p>captopril and potassium phosphates, iv both increase  serum potassium. Use Caution/Monitor. Risk of hyperkalemia. Monitor potassium.</p></li><li>dichlorphenamide<p>dichlorphenamide and potassium phosphates, iv both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>dichlorphenamide, potassium phosphates, iv.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Both drugs can cause metabolic acidosis.</p></li><li>potassium citrate/citric acid<p>potassium phosphates, iv and potassium citrate/citric acid both increase  serum potassium. Use Caution/Monitor.</p></li>